CTA, mHealth Companies Come Together to Promote Digital Therapeutics
The Consumer Technology Association has launched a new initiative aimed at highlighting the value of digital therapeutics, a platform that uses mHealth technology to assist and often replace office visits and medication.
- Roughly two dozen mHealth and telehealth companies are joining forces with the Consumer Technology Association to develop standards for digital therapeutics.
The CTA’s initiative aims to create a higher profile for connected health technologies that often replace or are used alongside pharmaceutical interventions, such as medications. They’re defined by the CTA as digital tools that use “software applications to enhance clinician decision making, optimize the dose and delivery of other forms of medical treatment through monitoring patient data in real time, or act as a standalone intervention.”
Telehealth advocates see this emerging field as an opportunity to improve remote patient monitoring and home-based care and reduce the need for expensive clinic visits and potentially addictive medications. Examples include rehab and therapy platforms, mHealth apps, wearables and augmented and virtual reality treatments.
By 